Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded PhaseHana M. El Sahly, Jacqueline M. Miller, Judith M. Martin et al.|New England Journal of Medicine|2021Cited by 661
Phase 3 Trial of mRNA-1273 during the Delta-Variant SurgeLindsey R. Baden, Jacqueline M. Miller, Hana M. El Sahly et al.|New England Journal of Medicine|2021Cited by 63